Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: RIBECCA
Total 1 results
Novartis Pharmaceuticals
Completed
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
Advanced Metastatic Breast Cancer
Germany
Sponsors and Collaborators
Outpatient Endovascular and Interventional Society
Department of Anesthesiology, North Denmark Regional Hospital
YASEMİN AYDIN KARTAL
Eastman Kodak Company
CARITAS Rundum zu Hause betreut
Grünenthal Denmark ApS
Invicta Medical Inc.
Sichuan Haisco Pharmaceutical Group Co., Ltd
Saint Pierre Institute - Palavas les Flots
Aga Khan Foundation, Pakistan
CeRSM
Gregorio Covino
Alessandra Palo
Erzurum Regional Training & Research Hospital
EMET Pharmaceuticals, LLC
Doterra Healing Hands Foundation
Axon Neuroscience SE
Irish Endocrine Society
Yancheng City NO.1 People's Hospital
Phramongkutklao College of Medicine and Hospital
View Full List
Medical Conditions
Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)
Modality of Discharge Instructions
Ferritin Threshold
Abdominal Compartment Syndrome
Major Depressive Disorder, Recurrent Episode, Severe
Bioequivalence, AUC, Cmax, Pharmacokinetics
Hypogonadism, Hypogonadotropic
Hemopathies
Central Motor Disorders
Chondrosis
Venous Puncture
Skeletal Muscle Energy Metabolism
Pelvic and Groin Areas Biopsy
Neutrophilia Acute
HIV Pre-exposure Prophylaxis Use
Mineralocorticoid Excess
Acute Endophthalmitis Post-operative
Osteopathic Manipulative Treatment
Human Risk Factors
Reading Disability
View Full List
Drug Interventions
LY2216684
Niraparib
Leuprolide acetate 11.25 mg
Amantadine Sulfate
Anti-PD1 antibody, nimotuzumab and capecitabine
Enteral oxygen therapy
Ranitidine
Risperidone
Pregabalin
Naltrexone 50 Mg + Inactive Marijuana (0% THC)
Carbetocin
Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
MYL-1501D product using manufacture process VI
Apatinib
Systemic intravenous lidocaine infusion
Pacritinib
Neridronate
Betamethasone
Test varnish
Lenalidomide
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Belarus
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Ecuador
Contract Research Organizations in Estonia
Contract Research Organizations in Ghana
Contract Research Organizations in Japan
Contract Research Organizations in Lebanon
Contract Research Organizations in Luxembourg
Contract Research Organizations in Malawi
Contract Research Organizations in Malta
Contract Research Organizations in Singapore
Contract Research Organizations in Türkiye
CRO list by country
CROs in Uganda
MRC/UVRI Uganda Research Unit
ACROSS Global
SGS
MCT
Dokumeds
All CROs in Uganda
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe